Published in Clin Transl Med on January 26, 2016
Phase IIa Dose-Expansion and Biomarker Study of OPB-111077 | NCT03158324
Mitochondria, cholesterol and cancer cell metabolism. Clin Transl Med (2016) 0.80
Effects of anti-human T lymphocyte immune globulins in patients: new or old. J Cell Mol Med (2016) 0.80
The Swi3 protein plays a unique role in regulating respiration in eukaryotes. Biosci Rep (2016) 0.75
The Antibiotic Drug Tigecycline: A Focus on its Promising Anticancer Properties. Front Pharmacol (2016) 0.75
The Chaperone TRAP1 As a Modulator of the Mitochondrial Adaptations in Cancer Cells. Front Oncol (2017) 0.75
Developmental transcriptome analysis and identification of genes involved in formation of intestinal air-breathing function of Dojo loach, Misgurnus anguillicaudatus. Sci Rep (2016) 0.75
The 2-oxoglutarate carrier promotes liver cancer by sustaining mitochondrial GSH despite cholesterol loading. Redox Biol (2017) 0.75
An integrated genomic analysis of human glioblastoma multiforme. Science (2008) 51.36
Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science (2009) 49.82
On the origin of cancer cells. Science (1956) 49.55
Comprehensive molecular portraits of human breast tumours. Nature (2012) 47.39
Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med (2012) 44.56
Comprehensive molecular characterization of human colon and rectal cancer. Nature (2012) 34.13
Recurring mutations found by sequencing an acute myeloid leukemia genome. N Engl J Med (2009) 33.09
IDH1 and IDH2 mutations in gliomas. N Engl J Med (2009) 32.41
Cancer genome landscapes. Science (2013) 25.33
The clonal evolution of tumor cell populations. Science (1976) 24.39
Signatures of mutational processes in human cancer. Nature (2013) 21.63
Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med (2013) 19.87
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature (2009) 19.65
Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature (2010) 17.38
The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. Cancer Cell (2010) 13.13
Clonal evolution in cancer. Nature (2012) 11.07
Comprehensive molecular profiling of lung adenocarcinoma. Nature (2014) 11.02
Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha. Science (2009) 10.78
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer (2007) 10.20
Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. Cancer Cell (2012) 9.88
Otto Warburg's contributions to current concepts of cancer metabolism. Nat Rev Cancer (2011) 9.68
Comprehensive molecular characterization of urothelial bladder carcinoma. Nature (2014) 8.48
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature (2012) 8.31
Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet (2002) 8.19
Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia. Nature (2011) 7.94
Analysis of the IDH1 codon 132 mutation in brain tumors. Acta Neuropathol (2008) 7.79
Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas. Acta Neuropathol (2009) 7.73
IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors. Hum Mutat (2009) 7.68
THE METABOLISM OF TUMORS IN THE BODY. J Gen Physiol (1927) 7.64
Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res (1991) 6.99
Reductive carboxylation supports growth in tumour cells with defective mitochondria. Nature (2011) 6.57
Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. Nature (2013) 6.53
Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells. J Biol Chem (1979) 6.53
IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas. Am J Pathol (2009) 6.43
Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med (2011) 6.15
Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer. Oncogene (2009) 5.81
IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours. J Pathol (2011) 5.73
Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations. J Exp Med (2010) 5.68
Spatial and temporal diversity in genomic instability processes defines lung cancer evolution. Science (2014) 5.63
Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins. Cancer Res (2004) 5.57
ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science (2008) 5.54
Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of α-ketoglutarate to citrate to support cell growth and viability. Proc Natl Acad Sci U S A (2011) 5.24
Synthetic lethal screen identification of chemosensitizer loci in cancer cells. Nature (2007) 4.70
The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma. Cell Cycle (2009) 4.69
Rev-erbalpha, a heme sensor that coordinates metabolic and circadian pathways. Science (2007) 4.68
Mutational analysis of IDH1 codon 132 in glioblastomas and other common cancers. Int J Cancer (2009) 4.45
Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing. Science (2014) 4.28
How Darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicine. Br J Cancer (2010) 4.19
Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. Hum Mol Genet (2005) 4.12
Identification of heme as the ligand for the orphan nuclear receptors REV-ERBalpha and REV-ERBbeta. Nat Struct Mol Biol (2007) 4.10
How cancer metabolism is tuned for proliferation and vulnerable to disruption. Nature (2012) 3.77
Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic Biol Med (1995) 3.75
Glutamine and cancer: cell biology, physiology, and clinical opportunities. J Clin Invest (2013) 3.46
The architecture of respiratory complex I. Nature (2010) 3.43
Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function. Nature (2014) 3.34
Evolution of the cancer genome. Nat Rev Genet (2012) 3.24
Complex I-mediated reactive oxygen species generation: modulation by cytochrome c and NAD(P)+ oxidation-reduction state. Biochem J (2002) 3.13
Mitochondrial energetics and therapeutics. Annu Rev Pathol (2010) 3.07
Cancer metabolism: facts, fantasy, and fiction. Biochem Biophys Res Commun (2004) 3.06
Mitochondrial genome acquisition restores respiratory function and tumorigenic potential of cancer cells without mitochondrial DNA. Cell Metab (2015) 3.06
Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping. Oncologist (2011) 3.05
Distinct clinical and biologic characteristics in adult acute myeloid leukemia bearing the isocitrate dehydrogenase 1 mutation. Blood (2010) 3.03
PGC-1α mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis. Nat Cell Biol (2014) 3.02
Ketones and lactate "fuel" tumor growth and metastasis: Evidence that epithelial cancer cells use oxidative mitochondrial metabolism. Cell Cycle (2010) 3.00
Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes. Nat Genet (2014) 2.91
IDH mutations in glioma and acute myeloid leukemia. Trends Mol Med (2010) 2.83
Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome. Nat Genet (2011) 2.74
Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors. Genes Dev (2012) 2.70
Intracellular free amino acid concentration in human muscle tissue. J Appl Physiol (1974) 2.69
IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis. Leukemia (2010) 2.65
Biological and therapeutic impact of intratumor heterogeneity in cancer evolution. Cancer Cell (2015) 2.57
The citric acid cycle and the Szent-Györgyi cycle in pigeon breast muscle. Biochem J (1940) 2.52
The evolution of free radicals and oxidative stress. Am J Med (2000) 2.52
An essential role for free radicals and derived species in signal transduction. FASEB J (1997) 2.50
Nuclear and mitochondrial compartmentation of oxidative stress and redox signaling. Annu Rev Pharmacol Toxicol (2006) 2.48
Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas. Oncogene (2012) 2.41
Impact of IDH1 R132 mutations and an IDH1 single nucleotide polymorphism in cytogenetically normal acute myeloid leukemia: SNP rs11554137 is an adverse prognostic factor. J Clin Oncol (2010) 2.38
Heme is involved in microRNA processing. Nat Struct Mol Biol (2006) 2.27
Regulation of protein synthesis by heme-regulated eIF-2 alpha kinase. Trends Biochem Sci (1995) 2.25
Oxidative stress and apoptosis: impact on cancer therapy. J Pharm Sci (2007) 2.25
Inborn and acquired metabolic defects in cancer. J Mol Med (Berl) (2011) 2.06
Upsides and downsides of reactive oxygen species for cancer: the roles of reactive oxygen species in tumorigenesis, prevention, and therapy. Antioxid Redox Signal (2012) 2.05
Mitochondrial capture by a transmissible cancer. Science (2011) 1.98
A new concept for energy coupling in oxidative phosphorylation based on a molecular explanation of the oxygen exchange reactions. Proc Natl Acad Sci U S A (1973) 1.96
Haem homeostasis is regulated by the conserved and concerted functions of HRG-1 proteins. Nature (2008) 1.95
Structure of the membrane domain of respiratory complex I. Nature (2011) 1.93
SDH mutations in cancer. Biochim Biophys Acta (2011) 1.92
Acetate is a bioenergetic substrate for human glioblastoma and brain metastases. Cell (2014) 1.90
Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel? Nat Rev Cancer (2014) 1.89
Glutamine fuels a vicious cycle of autophagy in the tumor stroma and oxidative mitochondrial metabolism in epithelial cancer cells: implications for preventing chemotherapy resistance. Cancer Biol Ther (2011) 1.85
Haem can bind to and inhibit mammalian calcium-dependent Slo1 BK channels. Nature (2003) 1.84
On respiratory impairment in cancer cells. Science (1956) 1.82
Acetate dependence of tumors. Cell (2014) 1.80
NF-κB controls energy homeostasis and metabolic adaptation by upregulating mitochondrial respiration. Nat Cell Biol (2011) 1.77
The role of glutamine in the oxidative metabolism of malignant cells. Cancer Res (1972) 1.76
Mitochondria damage checkpoint, aging, and cancer. Ann N Y Acad Sci (2006) 1.76
Therapeutic strategies by modulating oxygen stress in cancer and inflammation. Adv Drug Deliv Rev (2009) 1.68
Magnetic resonance of 2-hydroxyglutarate in IDH1-mutated low-grade gliomas. Sci Transl Med (2012) 1.67
Contribution by different fuels and metabolic pathways to the total ATP turnover of proliferating MCF-7 breast cancer cells. Biochem J (2002) 1.65
Analysis of glutamine dependency in non-small cell lung cancer: GLS1 splice variant GAC is essential for cancer cell growth. Cancer Biol Ther (2012) 1.56